Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cell Signaling 2020

About Cell Signaling 2020 Conference

Conference series is organizing Cell Signaling conference in 2020 at London, UK. This conference will explore the advances in Cell Signaling Technologies, Cell Metabolism, Medical Approaches, Oncology, Translational Oncology, Computational Technologies, etc.

Conference Series invites the participants from all over the globe to take part in “3rd Annual Summit on Cell Signaling & Cancer Therapy” during May 29-30, 2020 at London, UK. Scientific sessions designed for this conference will assist the attendees and participants to learn extremes.

The meeting aims to bring together the pioneers in both basic and translational cancer research and cover the research studies fundamentals of cancer cells and the hormone responses, cancer-controlling proteins, cell signaling and growth, novel diagnostic methods, new-generation molecular targeted therapies and immune treatments.

Importance & Scope:

Cancer is a complex disease caused by genetic and/or epigenetic changes in one cell or a group of cells. These variations interrupt ‘normal’ cell function and cause cancerous cells to over proliferate and avoid mechanisms which control their growth, division, and migration. Many of these ‘interruptions’ map to specific cell signaling pathways. The bond between cell signaling and cancer, focuses the key signaling pathways which are involved in cancer, and determines how critical mediators of aberrant signaling can be turned into therapeutic targets for cancer.

Why to attend?

In the light of this theme, the conference series aims to disseminate the developments of research in cancer therapy to the worldwide by creating a platform for active participation, exchange of expertise and ideas from researchers, scientists and students through invited plenary lectures, symposia, workshops, oral and poster sessions of unsolicited contributions.

Target Audience:

The 3rd Annual summit on Cell Signaling and Cancer Therapy 2020 brings together:

  • Clinical organizations
  • Pharmaceutical researchers
  • Computational Bioinformaticians
  • Educational institutes
  • Surgical Cancer Researchers
  • Translational Oncologists
  • Practicing cancer biologists in training
  • Other healthcare professionals

Sessions/Tracks

We bring up the 3rd Annual Summit on Cell Signaling & Cancer Therapy with its powerful 2 day agenda. Cell Signaling 2020 is designed to take place at the most fascinating city London, UK during May 29-30, 2020.

We focus on bringing together world's most productive visionaries and leading researchers to share their research works and results in the field of Cancer Therapy & Cell Signaling. Take a deep dive into the newest technologies made in the field with the enlightening talks of our Speakers which will help in broadening your horizons.

Network with great people at the beautiful environment of London!

Track 1: Cell Signaling

Cell Signaling is the part of any correspondence procedure which directs simple activities of cells and organizes multiple-cell actions. The capacity of cells to see and effectively react to their microenvironment is the premise of improvement, tissue fix, and insusceptibility, just as would be expected tissue homeostasis. It has been most widely considered with regards to human diseases and indicating between the cells of a solitary life form.

Track 2: Cancer Therapeutics

Cancer therapy explains the behaviour of cancer in a patient, frequently with medical procedure, chemotherapy and radiotherapy. Some of the cancer types have the availability of Targeted therapies. A cancer patient may get a many kinds of treatment, including those planned for diminishing the indications of disease, for example, torment.

Track 3: Cancer Biomarkers

Cancer biomarker alludes to a substance or process that is demonstrative of the potency of generation of tumor in the body. A biomarker might be a particle emitted by a tumour or a particular reaction of the body in the vicinity of disease. Hereditary, epigenetic, proteomic, glycomic and imaging biomarkers can be utilized for malignancy determination, anticipation and the study of disease transmission. In a perfect world, such biomarkers can be tested in non-obtrusively gathered bio-fluids like blood or serum.

Track 4: Cell & Gene Therapy

Cell therapy or cytotherapy is the transfer of cells into a patient with a goal of curing the illness. Initially blood transfusions have been practiced routine as they considered being the first type of cell therapy. Later, Bone marrow transplantation has also developed a well-established concept which includes treatment with much kind of blood disorders including anaemia, leukaemia, lymphoma and rare immunodeficiency diseases. Gene therapy essentially involves the overview or modification of genetic material among the cell or organism with associate intention of curing of the sickness.

Track 5: Radiation & Chemotherapy

Cancer chemotherapy includes the selection of drugs and dose levels, which will destroy circulated cancer cells, without causing severe host toxicity. Depending on the primary location and the extension of the disease, chemotherapy can be curative or palliative. Radiation therapy uses high energy particle or radiation or waves such as x-rays, gamma rays, electron beams, protons to destroy or shrink Cancer cell. When compared to normal cell, the Cancer cells grow and divide faster, radiation works by making small breaks in the DNA inside the cells. Cancer cells whose DNA is damaged by radiation stops dividing or die.

Track 6: Cell Metabolism

Cellular metabolism is a fundamental biological process in cellular homeostasis and organismal physiology with implications in other areas of research such as cancer, developmental biology, immunology and stem cell research. Developments in these arenas takes a special position for the given increasing occurrence of obesity, diabetes, hypertension, and related maladies in the developed world.

Track 7: Cancer Genetics

Cancer is a genetic disease & is caused by certain changes to genes that control the way our cells function, especially how they grow and divide. These variations contain mutations in the DNA that makes up our genes. There are few types of cancers which run into certain families but mostly cancers are not linked to the genes which we inherit from our parents. Gene changes that start in a single cell over the course of a person's life cause most cancers. Some people are genetically disposed to develop certain types of cancer.

Track 8: Cancer Stem Cell

Cancer Stem Cell hypothesizes the presence of a little populace of diseased cells with characteristic properties like protection from traditional radio-chemotherapy regiments and increased metastatic potential. Clinically, the forceful idea of CSCs has been appeared to connect with tumour repeat, metastatic spread, and generally very low patient result over various malignant growth subtypes. Separation of CSC’s has been achieved through the use of cell surface markers by the useful contrasts among CSCs and remaining tumour cells have been portrayed through expansion, separation, and constraining weakening measures.

Track 9: Signaling Pathways & Diseases

Signaling pathway characterizes a gathering of molecules in a cell that work together to control at least one cell capacities, for example, cell division or cell passing. After the main particle in a pathway gets a sign, it enacts another molecule. An enormous number of diseases are brought about by surrenders in flagging pathways. So as to show the significance and procedures of cell correspondence, this course will concentrate on cell signaling components and illnesses coming about because of their breakdown, for example, malignant growth, stroke, and neuron degeneration.

Track 10: Cell Biology

Cell is the basic well-designed unit of life. It is likewise a part of science that reviews the various structures and elements of the cell and spotlights for the most part on the possibility of the cell as the fundamental unit of life. Cells comprise of cytoplasm encased inside a film, which contains numerous biomolecules, for example, proteins and nucleic acids. Cell study is done on both minute and naturally visible level. Research in cell science is firmly identified with hereditary qualities, natural chemistry, immunology and formative science.

Track 11: Cancer Pharmacology & Cytopathology

Cancer pharmacology plays a key role in tranquilize improvement. In both the research facility and the center, it needs to adjust to the changing essence of medication improvement by setting up trial models and target orientated methodologies. It also focuses on evolving new methods to the clinical treatment of cancer by connecting the fields of molecular carcinogenesis, biochemical pharmacology, radiation biology, and clinical pharmacology. Cytopathology is a part of pathology that reviews and analyses infections on the cell level. Cytopathology is commonly utilized on tests of free cells or tissue pieces, rather than histopathology, which concentrates entire tissues.

Track 12: Signal Transduction

It is the procedure by which a compound or physical sign is transferred through a cell as a movement of molecule events, most normally protein phosphorylation catalyzed by protein kinases, which at last outcomes in a cell reaction. The progressions evoked by ligand binding (or sign detecting) in a receptor offer ascent to a biochemical course, which is a chain of biochemical occasions as a signaling pathway.

Track 13: Cancer Metastasis

Cancer that spread to an alternate piece of the body from where it began is called metastasis For example; a breast cancer that spread to the liver is referred to as metastatic breast cancer. The most widely recognized destinations where malignant growth spreads are the bone, liver and lung. The clinical sign of metastasis in an imperative organ is a definitive period of malignant growth movement and the principle wrongdoer of disease related mortality.

Track 14: Cancer Vaccines

A disease immunization is an antibody that either treats existing cancer or averts advancement of a malignancy. Antibodies that treat existing cancer growth are known as restorative disease immunizations. A few considerable lot of the antibodies are "autologous", being set up from tests taken from the patient, and are explicit to that patient. It is by and by apparent that various human tumour antigens can be seen by the sheltered system. These tumour antigens can be portrayed into a couple of social events including danger testis, detachment, tissue specific, over-conveyed, and viral-related antigens.

Track 15: Protein Signaling & Neuronal Signaling

Protein and intracellular signaling peptides for the most part are peptides and proteins which are engaged with transmission of sign or sign transduction over the layer everything being equal. Signals as second flag-bearers, hormones, proteins and other organic molecules which are perceived by cell surface receptors that move their reaction to other intracellular Signaling peptides and Protein like Transcriptor Factor. The comprehensively conveyed monoaminergic synapse serotonin applies its activities by means of 14 classes of receptor. In many Signaling pathways, many kind of elements have been confined by sub-atomic hereditary examinations and entire genome investigation.

Market Analysis

Cell Signaling is the part of any correspondence procedure which directs simple activities of cells and organizes multiple-cell actions. The capacity of cells to see and effectively react to their microenvironment is the premise of improvement, tissue fix, and insusceptibility, just as would be expected tissue homeostasis.

Cancer therapy explains the behaviour of cancer in a patient, frequently with medical procedure, chemotherapy and radiotherapy. Some of the cancer types has the availability of Targeted therapies. A cancer patient may get a many kinds of treatment, including those planned for diminishing the indications of disease, for example, torment.

Conference Series welcomes you all to the “3rd Annual Summit on Cell Signaling & Cancer Therapy” which is scheduled during May 29-30, 2020 at London UK with the theme “Enlightening the evolutions and exploring the new horizons in Cancer”. The Committee is looking forward to organize an exceptional meeting with an interesting sessions and to meet new people from different parts of the globe, where one can share one’s subject and passion.

Importance and Scope:

Cell Signaling & Cancer Therapy 2020 conducts a wide range of Sessions and Tracks which provides the participants and all the attendees with an opportunity to extend their information in the subject and interact with professionals in the field of Cancer & Oncology. The agenda of the conference highlights new and advanced treatments of cancer with interesting Sessions such as Symposia, Workshops, Plenary talks, Keynote Presentations, Young Researchers Forum and Poster Sessions.

Industries Associated with Oncology and Cancer Research

  • Roche
  • Celgene Corporation
  • Johnson & Johnson
  • Pfizer Inc.
  • Bristol-Myers Squibb
  • Novartis
  • Merck & Co., Inc.
  • AstraZeneca
  • AbbVie
  • Eli Lilly


Market Analysis:

Cell signaling market is expected to grow from USD 2.53 billion in 2017 to USD 3.51 billion by 2022, at a CAGR of 6.8%. This report aims to estimate the market size and potential for growth in the cell signaling market across different segments such as type, product, technology, pathway, applications, and regions.

Cancer is the second leading cause of death globally, and about 1 in 6 deaths is due to cancer. The rising number of patients suffering from chronic diseases such as cancer, diabetes, cardiovascular disorders, and neurological conditions has led to an increase in cell signaling-based research across the globe. According to the 2014 report of the American Heart Foundation, nearly 17.3 million people die due to cardiovascular diseases (CVDs) each year, accounting for 30% of global deaths. This number is projected to increase to 23.6 million by 2030.

This report studies the global market size of Cancer Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Drugs in these regions, this report categorizes the global Cancer Drugs market by players/brands, region, type and application and also studies the global market status, competition landscape,  growth rate, future trends, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

Societies with Oncology and Cancer research:

  • Society of Oncology and Cancer Research of Nigeria (SOCRON)
  • European society for medical oncology
  • American Society of Clinical Oncology
  • American Institute for Cancer Research (AICR)
  • National Foundation for Cancer Research
  • Cancer Research Institute
  • Institute of Cancer Research, London
  • National Cancer Institute
  • Cancer Research UK
  • National Institutes of Health (NIH)
  • Breast Cancer Research Foundation
  • Amgen
  • World Cancer Research Fund International
  • AstraZeneca
  • Genentech
  • Prevent Cancer Foundation
  • Netherlands Cancer Institute
  • Walker Cancer Research Institute
  • National Cancer Centre Singapore

To Collaborate Scientific Professionals around the World

Conference Date May 29-30, 2020

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by